Ryan Specialty Holdings grants 22,920 stock options

Ryan Specialty Holdings reported that EVP & CHRO Michael Conklin received a grant of 22,920 Executive Chairman stock options on August 4, 2026.

Rhea-AI Filing Summary

Ryan Specialty Holdings reported that EVP & CHRO Michael Conklin received a grant of 22,920 Executive Chairman stock options on August 4, 2026. The options have a $43.63 exercise price, expire on August 4, 2036, and vest in three equal installments on October 1, 2029, 2030 and 2031. Following the award, he holds 22,920 derivative securities directly. The options are exercisable on a 1-for-1 basis into Class A common stock, and the grant was approved by the compensation and governance committee for purposes of Rule 16(b)(3).

Insider Trade Summary

Grant/Award: 22,920 shares

Grant/Award 1 txn

Insider Conklin Michael

Role EVP & CHRO

Type	Security	Shares	Price	Value
Grant/Award	Executive Chairman Stock Option F1	22,920	$0.00	$0.00

Holdings After Transaction: Executive Chairman Stock Option — 22,920 contracts (Direct)

Footnotes (1)

1. F1. The stock options vest in equal amounts on October 1, 2029, 2030 and 2031 and are exercisable on a 1-for-1 basis for shares of Class A common stock, par value $0.001 per share, of the Issuer. Such grant was approved by the compensation and governance committee of the board of the Issuer for the purposes of rule 16(b)(3).

Key Figures

Stock options granted: 22,920 options Exercise price: $43.63 per share Expiration date: August 4, 2036 +3 more

6 metrics

Stock options granted 22,920 options Executive Chairman Stock Option grant to Michael Conklin on August 4, 2026

Exercise price $43.63 per share Conversion or exercise price of the granted stock options

Expiration date August 4, 2036 Expiration of Executive Chairman Stock Option grant

Underlying shares 22,920 shares Underlying Class A common stock issuable on a 1-for-1 basis

Vesting dates Oct 1, 2029; Oct 1, 2030; Oct 1, 2031 Three equal vesting installments for the stock options

Holdings after grant 22,920 derivative securities Total options held directly by Michael Conklin after this transaction

Key Terms

Executive Chairman Stock Option, Class A common stock, Rule 16(b)(3)

3 terms

Executive Chairman Stock Option financial

"An Executive Chairman Stock Option was granted to Michael Conklin as a derivative security."

Class A common stock financial

"The options are exercisable on a 1-for-1 basis for shares of Class A common stock."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Rule 16(b)(3) regulatory

"The grant was approved by the compensation and governance committee for purposes of Rule 16(b)(3)."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did RYAN report for Michael Conklin?

RYAN reported that EVP & CHRO Michael Conklin received a grant of 22,920 stock options on August 4, 2026. These Executive Chairman stock options are exercisable into Class A common stock and represent a compensation-related award rather than an open-market purchase or sale.

What is the exercise price of Michael Conklin’s new RYAN options?

The newly granted options to Michael Conklin carry an exercise price of $43.63 per share. They are exercisable on a 1-for-1 basis into Class A common stock, providing potential future equity exposure if the share price exceeds this exercise price.

How many RYAN options does Michael Conklin hold after this Form 4?

After this reported transaction, Michael Conklin holds 22,920 derivative securities related to Ryan Specialty Holdings. These options were all acquired in this single grant and are held directly, subject to the vesting schedule and expiration terms disclosed.

When do Michael Conklin’s new RYAN stock options vest?

The granted stock options vest in three equal installments on October 1, 2029, 2030 and 2031. This means one-third of the options becomes exercisable on each of those dates, aligning the long-term incentive with multi-year service and performance horizons.

When do the RYAN stock options granted to Michael Conklin expire?

The Executive Chairman stock options granted to Michael Conklin expire on August 4, 2036. After that date, any unexercised portion of the 22,920 options will lapse, limiting the exercise window to roughly a decade after the original grant date.

Were Michael Conklin’s RYAN options approved by a board committee?

Yes. The filing states the grant was approved by the compensation and governance committee of Ryan Specialty Holdings’ board for purposes of Rule 16(b)(3). This committee-level approval is referenced directly in the transaction’s footnote disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 04:58 PM Accepted by SEC EDGAR 08/06/2026 - 04:57 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Conklin Michael

(Last) (First) (Middle)

155 NORTH WACKER DRIVE, SUITE 4000

(Street)

CHICAGO ILLINOIS 60606

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RYAN SPECIALTY HOLDINGS, INC. [ RYAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CHRO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Executive Chairman Stock Option	$43.63	08/04/2026		A		22,920		(1)	08/04/2036	Class A Common Stock	22,920	$0	22,920	D

Explanation of Responses:

1. The stock options vest in equal amounts on October 1, 2029, 2030 and 2031 and are exercisable on a 1-for-1 basis for shares of Class A common stock, par value $0.001 per share, of the Issuer. Such grant was approved by the compensation and governance committee of the board of the Issuer for the purposes of rule 16(b)(3).

Remarks:

	/s/ Mark S. Katz, as Attorney-in-Fact	08/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)